These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7018042)

  • 21. Selecting patients and inserting the Progestasert.
    Soderstrom RM
    Am J Gynecol Health; 1989; 3(3-S):17-8. PubMed ID: 12284993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro sperm penetration tests and PCTs in fertile women wearing different medicated IUDs (Cu and progesterone)].
    Bruno V; Dondero F; Moro M; Cerasard M; Carenza L
    Contracept Fertil Sex (Paris); 1986 Feb; 14(2):143-9. PubMed ID: 12267800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Copper IUDs.
    Thiery M
    Contracept Deliv Syst; 1983 Jul; 4(3):175-85. PubMed ID: 12265360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective randomized study of the copper 7, Multiload Cu 250 and copper 220C IUDS in Singapore.
    McCarthy TG; Lim LS; Karim SM; Ratnam SS
    Singapore Med J; 1986 Jun; 27(3):220-4. PubMed ID: 3532346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Three dimensional reconstruction of human endometrial spiral arteries preinsertion and postinsertion of IUD].
    Huang L; Chen L; Chen Q
    Zhonghua Fu Chan Ke Za Zhi; 1996 Sep; 31(9):523-5. PubMed ID: 9275421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative clinical trial of two models of copper IUDs in Campinas: the T-Cu 200 and the Multiload-Cu 250].
    Diaz J; Faundes A; Diaz MM; Pinotti JA
    J Bras Ginecol; 1985; 95(8):363-6. PubMed ID: 12280370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum-prolactin levels in lactating women using the Progestasert system.
    Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
    Contracept Deliv Syst; 1981 Apr; 2(1):121-6. PubMed ID: 12336863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The rise and fall and rise of the IUD.
    Burnhill MS
    Am J Gynecol Health; 1989; 3(3-S):6-10. PubMed ID: 12285000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nova-T and Copper-T 200 in a five year's clinical comparison].
    Nygren KG; Allonen H; Nielsen NC; Luukkainen T; Pyorala T
    Contracept Fertil Sex (Paris); 1983 Nov; 11(11):1179-84. PubMed ID: 12312701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A reanalysis of the Cu-7 intrauterine contraceptive device clinical trial and the incidence of pelvic inflammatory disease: a paradigm for assessing intrauterine contraceptive device safety.
    Roy S; Azen C
    Am J Obstet Gynecol; 1994 Jun; 170(6):1606-13; discussion 1613-6. PubMed ID: 8203417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Our experience with intrauterine devices (IUD) for birth control].
    Vidal JJ; Flores F; López de Medina R; Aisa E; Villar JM
    Acta Obstet Ginecol Hisp Lusit; 1980 Feb; 28(2):87-94. PubMed ID: 7395474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The morphometric study of endometrial spiral arterioles before and after insertion of gamma CuI and TCu 220C intrauterine devices].
    Liu Z; Chen Q; Ni X
    Zhonghua Fu Chan Ke Za Zhi; 1998 Apr; 33(4):232-4. PubMed ID: 10682472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ovulatory menstrual cycle profile as affected by Progestasert and the Cu-T. Comparative analytical studies].
    Hary J; Rindt W
    Bull Soc Sci Med Grand Duche Luxemb; 1979; 116(2):217-24. PubMed ID: 121065
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum cortisol level in lactating women using the Progestasert system.
    Askalani H; Badraoui MH; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
    Contracept Deliv Syst; 1981 Apr; 2(1):133-8. PubMed ID: 12336865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The intrauterine device today.
    Rioux JE
    J SOGC; 1993 Oct; 15(8):921-4. PubMed ID: 12318529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.